The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
An Effective Approach to Prevent Immune Rejection of Human ESC-Derived Allografts
Open accessAbstract
Summary Human embryonic stem cells (hESCs) hold great promise for cell therapy as a source of diverse differentiated cell types. One key bottleneck to realizing such potential is allogenic immune rejection of hESC-derived cells by recipients. Here, we optimized humanized mice (Hu-mice) reconstituted with a functional human immune system that mounts a vigorous rejection of hESCs and their derivatives. We established knock-in hESCs that constitutively express CTLA4-Ig and PD-L1 before and after differentiation, denoted CP hESCs. We then demonstrated that allogenic CP hESC-derived teratomas, fibroblasts, and cardiomyocytes are immune protected in Hu-mice, while cells derived from parental hESCs are effectively rejected. Expression of both CTLA4-Ig, which disrupts T-cell co-stimulatory pathways, and PD-L1, which activates T-cell inhibitory pathway, is required to confer immune protection as neither was sufficient on their own. These findings are instrumental for developing a strategy to protect hESC-derived cells from allogenic immune responses without requiring systemic immune suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717
Immunogenicity of induced pluripotent stem cells
Zhao, T., Zhang, Z.-N., Rong, Z., & Xu, Y. (2011) · Nature · doi:10.1038/nature10135 · Cited by 1,444
Self-citationEmbryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
Fife, B. T., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00662.x · Cited by 1,054
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
Kawai, T., Sachs, D. H., Sykes, M., & Cosimi, A. B. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1213779 · Cited by 1,024
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
Kawai, T., Cosimi, A. B., Spitzer, T. R., Tolkoff-Rubin, N., Suthanthiran, M., Saidman, S. L., Shaffer, J., Preffer, F. I., Ding, R., Sharma, V., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071074 · Cited by 982
Humanized mice for immune system investigation: progress, promise and challenges
Shultz, L. D., Brehm, M. A., Garcia-Martinez, J. V., & Greiner, D. L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3311 · Cited by 979
Vodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
The enemy within: keeping self-reactive T cells at bay in the periphery
Walker, L. S. K., & Abbas, A. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri701 · Cited by 596
Dubois, N. C., Craft, A. M., Sharma, P., Elliott, D. A., Stanley, E. G., Elefanty, A. G., Gramolini, A., & Keller, G. (2011) · Nature Biotechnology · doi:10.1038/nbt.2005 · Cited by 544
Lan, P., Tonomura, N., Shimizu, A., Wang, S., & Yang, Y.-G. (2006) · Blood · doi:10.1182/blood-2005-11-4388 · Cited by 478
Self-citationRegulatory immune cells in transplantation
Wood, K. J., Bushell, A., & Hester, J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3227 · Cited by 431
Human Hemato-Lymphoid System Mice: Current Use and Future Potential for Medicine
Rongvaux, A., Takizawa, H., Strowig, T., Willinger, T., Eynon, E. E., Flavell, R. A., & Manz, M. G. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095921 · Cited by 348
Species differences in the structure and function of the immune system
Haley, P. J. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00043-x · Cited by 336
Ledran, M. H., Krassowska, A., Armstrong, L., Dimmick, I., Renström, J., Lang, R., Yung, S., Santibanez-Coref, M., Dzierzak, E., Stojkovic, M., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.001 · Cited by 291
Turning straw into gold: directing cell fate for regenerative medicine
Cohen, D. E., & Melton, D. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2938 · Cited by 287
Selective Ablation of Human Embryonic Stem Cells Expressing a “Suicide” Gene
Schuldiner, M., Itskovitz‐Eldor, J., & Benvenisty, N. (2003) · STEM CELLS · doi:10.1634/stemcells.21-3-257 · Cited by 286
Davis, R. P., Ng, E. S., Costa, M., Mossman, A. K., Sourris, K., Elefanty, A. G., & Stanley, E. G. (2008) · Blood · doi:10.1182/blood-2007-06-093609 · Cited by 235
Prodrug-activating systems in suicide gene therapy
Springer, C. J., & Niculescu-Duvaz, I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10001 · Cited by 229
Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment
Fugier-Vivier, I. J., Rezzoug, F., Huang, Y., Graul-Layman, A. J., Schanie, C. L., Xu, H., Chilton, P. M., & Ildstad, S. T. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041399 · Cited by 177
Modeling Disease in Human ESCs Using an Efficient BAC-Based Homologous Recombination System
Song, H., Chung, S.-K., & Xu, Y. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2009.11.016 · Cited by 163
Self-citationGenetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy
Howden, S. E., Gore, A., Li, Z., Fung, H.-L., Nisler, B. S., Nie, J., Chen, G., McIntosh, B. E., Gulbranson, D. R., Diol, N. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103388108 · Cited by 154
A Model for Personalized in Vivo Analysis of Human Immune Responsiveness
Kalscheuer, H., Danzl, N. M., Onoe, T., Faust, T., WINCHESTER, R. J., Goland, R., Greenberg, E. M., Spitzer, T. R., Savage, D. G., Tahara, H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003481 · Cited by 130
Self-citationTarget Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury
Bretzner, F., Gilbert, F., Baylis, F. E., & Brownstone, R. M. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.04.012 · Cited by 129
Tonomura, N., Habiro, K., Shimizu, A., et al. (2008) · Blood · doi:10.1182/blood-2007-11-121319 · Cited by 127
Highly enriched cardiomyocytes from human embryonic stem cells
Xu, X. Q., Zweigerdt, R., Soo, S. Y., Ngoh, Z. X., Tham, S. C., Wang, S. T., Graichen, R., Davidson, B. P., Colman, A., & Sun, W. Y. (2008) · Cytotherapy · doi:10.1080/14653240802105307 · Cited by 113
Woods, N., Parker, A. S., Moraghebi, R., Lutz, M. K., Firth, A. L., Brennand, K., Berggren, W. T., Raya, Á., Belmonte, J. C. I., Gage, F. H., et al. (2011) · Stem Cells · doi:10.1002/stem.657 · Cited by 81
Concise Review: Immune Recognition of Induced Pluripotent Stem Cells
Boyd, A. S., Rodrigues, N. P., Lui, K. O., Fu, X., & Xu, Y. (2012) · Stem Cells · doi:10.1002/stem.1066 · Cited by 76
Self-citationProtecting against wayward human induced pluripotent stem cells with a suicide gene
Cheng, F., Ke, Q., Chen, F., Cai, B., Gao, Y., Ye, C., Wang, D., Zhang, L., Lahn, B. T., Li, W., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.023 · Cited by 76
Belatacept: from rational design to clinical application
Wekerle, T., & Grinyo, J. M. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01386.x · Cited by 71
Mouse models with human immunity and their application in biomedical research
Zhang, B., Duan, Z., & Zhao, Y. X. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00347.x · Cited by 67
Natural Killer Cells and the Immune Response in Solid Organ Transplantation
van der Touw, W., & Bromberg, J. S. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03086.x · Cited by 60
A Scalable Approach to Prevent Teratoma Formation of Human Embryonic Stem Cells
Rong, Z., Fu, X., Wang, M., & Xu, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383810 · Cited by 58
Self-citationWirth, E. D., LEBKOWSKI, J. S., & Lebacqz, K. A. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.04.008 · Cited by 37
Self-Renewal and Scalability of Human Embryonic Stem Cells for Human Therapy
Fu, X., & Xu, Y. (2011) · Regenerative Medicine · doi:10.2217/rme.11.18 · Cited by 30
Self-citationShuttle of lentiviral vectors via transplanted cells in vivo
Blömer, U., Gruh, I., Witschel, H., Haverich, A., & Martin, U. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302384 · Cited by 29
The immunosuppressive pipeline: Meeting unmet needs in liver transplantation
Selzner, N., Grant, D. R., Shalev, I., & Levy, G. A. (2010) · Liver Transplantation · doi:10.1002/lt.22193 · Cited by 27
Tian, C., Ansari, M. J., Paez-Cortez, J. R., Bagley, J., Godwin, J., Donnarumma, M., Sayegh, M. H., & Iacomini, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6762 · Cited by 23
Cited by
Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M., Nomura, M., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.02.005 · Cited by 581
Generation of hypoimmunogenic human pluripotent stem cells
Han, X., Wang, M., Duan, S., Franco, P. J., Kenty, J. H.-R., Hedrick, P., Xia, Y., Allen, A., Ferreira, L. M. R., Strominger, J. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902566116 · Cited by 363
Self-citationNext-generation stem cells — ushering in a new era of cell-based therapies
Kimbrel, E. A., & Lanza, R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0064-x · Cited by 275
Wang, B., Iriguchi, S., Waseda, M., Ueda, N., Ueda, T., Xu, H., Minagawa, A., Ishikawa, A., Yano, H., Ishi, T., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00730-z · Cited by 189
Translational strategies and challenges in regenerative medicine
Dimmeler, S., Ding, S., Rando, T. A., & Trounson, A. (2014) · Nature Medicine · doi:10.1038/nm.3627 · Cited by 179
Metadata
- Authors
- Rong, Z., Wang, M., Hu, Z., Stradner, M., Zhu, S., Kong, H., Yi, H., Goldrath, A., Yang, Y.-G., Xu, Y., & Fu, X.
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 14
- Issue
- 1
- Pages
- 121-130
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W1994170225
- Cited by
- 263
- References
- 42
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.